Neimeth International Pharmaceuticals Plc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was NGN 468.78 million compared to NGN 793.13 million a year ago. Net loss was NGN 189.51 million compared to net income of NGN 100.18 million a year ago.

Basic loss per share from continuing operations was NGN 0.04 compared to basic earnings per share from continuing operations of NGN 0.0527 a year ago.